Article
Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C.
Clinical epigenetics - 1 Jan 2018
Schenkel Laila C, Aref-Eshghi Erfan, Skinner Cindy, Ainsworth Peter, Lin Hanxin, Paré Guillaume, Rodenhiser David I, Schwartz Charles, Sadikovic Bekim
Abstract excerpt
Background: Claes-Jensen syndrome is an X-linked inherited intellectual disability caused by mutations in the KDM5C gene. Kdm5c is a histone lysine demethylase involved in histone modifications and chromatin remodeling. Males with hemizygous mutations in KDM5C present with intellectual disability and facial dysmorphism, while most heterozygous female carriers are asymptomatic. We hypothesized that loss of Kdm5c...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
